DANIELLE BOWEN: Open Payments
NPI 1063485035 · TOPSHAM, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 19 payments from 12 companies in 2025. Trend: 2023 $302 · 2024 $305 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $182 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $56 |
| AtriCure, Inc. | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Exelixis Inc. | 1 | $26 |
| Astellas Pharma Global Development | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
Products named: EPKINLY, ZYNLONTA, ATRICLIP LAA EXCLUSION SYSTEM, OPDIVO, ZENPEP, TAGRISSO, CABOMETYX, Vyloy.
Industry payments across ME — which companies pay providers there.
